Gerresheimer offers a complete package of primary packaging for biologics
The about important tendency forecast by pharmaceutical experts is the standing, worldwide increasing demand for biological drugs and biosimilars. With the recently founded, Gx Biological Solutions organization, Gerresheimer has installed a dedicated squad to serve the highly specific requirements in the biological play field.
The global biopharmaceuticals market is driven by diverse factors, such as the increase in the elderly population, surge in the prevalence of chronic diseases like cancer and diabetes, and growth in the adoption of biopharmaceuticals globally. Furthermore, a rise in strategic collaborations amongst biopharmaceuticals companies is as well anticipated to supplement the growth of the biopharmaceutical industry.
Biological drugs are specifically being used to treat, for example, rheumatism, diabetes, or cancer and are normally administered parenterally. They differ from conventional drugs in their molecular structure. Hence special demands on the primary packaging are to be taken care of. Gerresheimer has developed a consummate package of services and products for these biological drugs and biosimilars. This includes a dedicated, innovative product portfolio consisting of specialty syringes and vials, safety devices, and more than that run across the specific requirements of this continuously growing marketplace segment. At the aforementioned time, Gerresheimer as well offers a wide range of services, peculiarly for small and medium-sized biotech companies. Whether it is advised on the right primary packaging to exist used in the appropriate clinical phase or support with approval and regulatory processes, lab services, and much more.
Gx Biological Solutions – new founded team of specialists
At Pharmapack 2022 in Paris, Gerresheimer has presented its products for the prophylactic, innovative and sustainable packaging of biologicals. "We want to offer our customers in the pharmaceutical industry with customized packaging solutions for their biologics so that they tin be assured that all of their requirements are met 100%," said Stefan Verheyden, Global vice president of Gx Biological Solutions team.
Small Batch Production in Frg
As a leading manufacturer of syringes, injection vials too as cartridges and administration systems, Gerresheimer covers a very broad spectrum for the parenteral administration of biologicals within its portfolio. Smaller batch sizes are frequently requested when filling biological products. Hence Gerresheimer has invested in a small batch production facility in Wackersdorf – Germany. When the filled biological amanuensis is sensitive to its storage environment, the container must be individually adjusted to its properties. During the clinical evolution phase, Gerresheimer experts can support with communication on the correct primary packaging, syringe, or drug delivery device, equally well as with regulatory approval processes and much more.
Source: https://packagingsouthasia.com/type-of-article/industry-news/gerresheimer-offers-a-complete-package-of-primary-packaging-for-biologics/
0 Response to "Gerresheimer offers a complete package of primary packaging for biologics"
Post a Comment